239 related articles for article (PubMed ID: 12782583)
1. Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study.
Daoud SS; Munson PJ; Reinhold W; Young L; Prabhu VV; Yu Q; LaRose J; Kohn KW; Weinstein JN; Pommier Y
Cancer Res; 2003 Jun; 63(11):2782-93. PubMed ID: 12782583
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects.
Zhou Y; Gwadry FG; Reinhold WC; Miller LD; Smith LH; Scherf U; Liu ET; Kohn KW; Pommier Y; Weinstein JN
Cancer Res; 2002 Mar; 62(6):1688-95. PubMed ID: 11912141
[TBL] [Abstract][Full Text] [Related]
3. DNA microarrays identification of primary and secondary target genes regulated by p53.
Kannan K; Amariglio N; Rechavi G; Jakob-Hirsch J; Kela I; Kaminski N; Getz G; Domany E; Givol D
Oncogene; 2001 Apr; 20(18):2225-34. PubMed ID: 11402317
[TBL] [Abstract][Full Text] [Related]
4. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
Xi Y; Shalgi R; Fodstad O; Pilpel Y; Ju J
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2014-24. PubMed ID: 16609010
[TBL] [Abstract][Full Text] [Related]
5. DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1.
Kannan K; Kaminski N; Rechavi G; Jakob-Hirsch J; Amariglio N; Givol D
Oncogene; 2001 Jun; 20(26):3449-55. PubMed ID: 11423996
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
Huang Y; Tan M; Gosink M; Wang KK; Sun Y
Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells.
Spurgers KB; Coombes KR; Meyn RE; Gold DL; Logothetis CJ; Johnson TJ; McDonnell TJ
Oncogene; 2004 Mar; 23(9):1712-23. PubMed ID: 14647426
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle effects of topotecan alone and in combination with irradiation.
Ohneseit PA; Prager D; Kehlbach R; Rodemann HP
Radiother Oncol; 2005 May; 75(2):237-45. PubMed ID: 15890420
[TBL] [Abstract][Full Text] [Related]
9. Wild-type p53 protein potentiates cytotoxicity of therapeutic agents in human colon cancer cells.
Yang B; Eshleman JR; Berger NA; Markowitz SD
Clin Cancer Res; 1996 Oct; 2(10):1649-57. PubMed ID: 9816112
[TBL] [Abstract][Full Text] [Related]
10. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional responses to ionizing radiation reveal that p53R2 protects against radiation-induced mutagenesis in human lymphoblastoid cells.
Tsai MH; Chen X; Chandramouli GV; Chen Y; Yan H; Zhao S; Keng P; Liber HL; Coleman CN; Mitchell JB; Chuang EY
Oncogene; 2006 Jan; 25(4):622-32. PubMed ID: 16247478
[TBL] [Abstract][Full Text] [Related]
12. Lymphoblastoid cell lines differing in p53 status show clear differences in basal gene expression with minor changes after irradiation.
Zschenker O; Borgmann K; Streichert T; Meier I; Wrona A; Dikomey E
Radiother Oncol; 2006 Aug; 80(2):236-49. PubMed ID: 16905214
[TBL] [Abstract][Full Text] [Related]
13. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.
Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH
Cancer Res; 2001 Jun; 61(12):4910-5. PubMed ID: 11406570
[TBL] [Abstract][Full Text] [Related]
14. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S
Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping.
Reinhold WC; Kouros-Mehr H; Kohn KW; Maunakea AK; Lababidi S; Roschke A; Stover K; Alexander J; Pantazis P; Miller L; Liu E; Kirsch IR; Urasaki Y; Pommier Y; Weinstein JN
Cancer Res; 2003 Mar; 63(5):1000-11. PubMed ID: 12615715
[TBL] [Abstract][Full Text] [Related]
16. Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53.
Komarova EA; Diatchenko L; Rokhlin OW; Hill JE; Wang ZJ; Krivokrysenko VI; Feinstein E; Gudkov AV
Oncogene; 1998 Sep; 17(9):1089-96. PubMed ID: 9764819
[TBL] [Abstract][Full Text] [Related]
17. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
18. Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer.
Xi Y; Nakajima G; Schmitz JC; Chu E; Ju J
BMC Genomics; 2006 Apr; 7():68. PubMed ID: 16584549
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of p53(+/-) knockout and wild-type mice following diethylstilbestrol administration.
Salleh MN; Ismail P; Abdullah AS; Taufiq-Yap YH
IUBMB Life; 2004 Jul; 56(7):409-16. PubMed ID: 15545218
[TBL] [Abstract][Full Text] [Related]
20. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
